TY  - JOUR

T1  - A prospective evaluation of pulmonary, cardiac, and hepatic function (fn) in ‘tAnGo’: A randomized phase III trial of gemcitabine (G) in paclitaxel (T)-containing, epirubicin/cyclophosphamide (EC)-based, adjuvant chemotherapy (CT) for early stage breast cancer

JO  - Journal of Clinical Oncology

PY  - 2004/07/15

AU  - Poole CJ

AU  - Howard HC

AU  - Hiller L

AU  - Dunn JA

AU  - Wardley AM

AU  - Bowman A

AU  - Coleman RE

AU  - Fernando IN

AU  - Ritchie DM

AU  - Earl HM

ED  - 

DO  - DOI: 10.1200/jco.2004.22.14_suppl.821

PB  - American Society of Clinical Oncology (ASCO)

VL  - 22

IS  - 14_suppl

SP  - 821

EP  - 821

Y2  - 2025/10/10

ER  -